134 related articles for article (PubMed ID: 17273738)
1. Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis.
Begum S; Zhang Y; Shintani T; Toratani S; Sato JD; Okamoto T
Oncol Rep; 2007 Mar; 17(3):591-6. PubMed ID: 17273738
[TBL] [Abstract][Full Text] [Related]
2. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
[TBL] [Abstract][Full Text] [Related]
4. 1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.
Rosli SN; Shintani T; Toratani S; Usui E; Okamoto T
In Vitro Cell Dev Biol Anim; 2014 Oct; 50(9):802-6. PubMed ID: 24938357
[TBL] [Abstract][Full Text] [Related]
5. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
6. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1).
Higaki M; Shintani T; Hamada A; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):222-233. PubMed ID: 32185608
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
Johnstone S; Logan RM
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
[TBL] [Abstract][Full Text] [Related]
8. [Effect of FGF-BP on angiogenesis in squamous cell carcinoma].
Li W; Chen W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):465-7, 493. PubMed ID: 12910691
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 expression during experimental oral carcinogenesis. Its possible role in the induction of pre-malignant fibrosis.
Raimondi AR; Molinolo AA; Itoiz ME
J Oral Pathol Med; 2006 Apr; 35(4):212-7. PubMed ID: 16519768
[TBL] [Abstract][Full Text] [Related]
11. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
12. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
[TBL] [Abstract][Full Text] [Related]
13. Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells.
Shintani T; Higaki M; Okamoto T
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072393
[TBL] [Abstract][Full Text] [Related]
14. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.
Nathan CO; Franklin S; Abreo FW; Nassar R; de Benedetti A; Williams J; Stucker FJ
Laryngoscope; 1999 Aug; 109(8):1253-8. PubMed ID: 10443829
[TBL] [Abstract][Full Text] [Related]
15. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma.
Kitadai Y; Onogawa S; Kuwai T; Matsumura S; Hamada H; Ito M; Tanaka S; Yoshihara M; Chayama K
Oncol Rep; 2004 Feb; 11(2):315-9. PubMed ID: 14719061
[TBL] [Abstract][Full Text] [Related]
17. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D
Shintani T; Higaki M; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38713345
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma.
Johnstone S; Logan RM
Oral Oncol; 2006 Apr; 42(4):337-42. PubMed ID: 16144770
[TBL] [Abstract][Full Text] [Related]
19. VEGF expression from human dysplastic or malignant oral epithelium may be related to mast cell density and the subsequent angiogenetic phenomena.
Michailidou EZ; Markopoulos AK; Antoniades DZ
Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1467-73. PubMed ID: 22652447
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis.
Ruan M; Ji T; Wu Z; Zhou J; Zhang C
Int J Oral Maxillofac Surg; 2007 Feb; 36(2):159-64. PubMed ID: 17110085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
